Latest filing published 17 Sept 2026 for Tyra Biosciences, Inc., €6,834. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Todd Harris (chief executive) discloses dealings in Tyra Biosciences, Inc. to SEC (Form 4). We count 22 filings; the first trade dates from 17 September 2021 and the latest from 15 September 2026.
On the market, this insider has only sold: 8 sales, €2.9M in total. Outside the open market, there are 8 share grants and 5 option exercises.
On 17 September 2026 came the latest disclosure, a share grant for €6,834 in Tyra Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations